Skip to main content
General Medicine

Pralsetinib



General

Brand Names: U.S.

  • Gavreto

Indications

Use: Labeled Indications

Non-small cell lung cancer, metastatic RET fusion-positive: Treatment of metastatic RET fusion-positive non-small cell lung cancer (N...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

START 10-DAY FREE TRIAL
Subscribe Now
©2021 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved.

Enter An Access Code

 
We are unable to redeem your access code. Please try again another time.
Enter the code from your copy of The 5-Minute Clinical Consult or another access code to create an account.
×
×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept